DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H2 2016" report to their offering. Pharmaceutical and ...
ROCHESTER, MINN. -- About 40 percent of women past menopause have atrophic vaginitis, an inflammation of or an irritation of the vaginal tissues and a decrease in lubrication. The often-overlooked ...
The FDA has approved a 10mcg formulation of Vagifem (estradiol vaginal tablets, from Novo Nordisk) for the treatment of atrophic vaginitis due to menopause. This approval is based on clinical data ...
December 2, 2009 — The US Food and Drug Administration (FDA) has approved a low-dose (10 μg) formulation of estradiol vaginal tablets (Vagifem, Novo Nordisk) for the treatment of menopausal atrophic ...
Vaginitis is a condition involving inflammation of the vagina and the vulva, which may arise due to several different causes. Various types of infections may be responsible, in addition to reactions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback